| Literature DB >> 22342270 |
Roger Baskett1, Richard Crowell, Darren Freed, Nadia Giannetti, Christopher S Simpson.
Abstract
There have been significant advances in mechanical circulatory support during the past several years. Older pulsatile models of left ventricular assist devices (LVADs) (also known as VADs) have shown improved outcomes compared with medical therapy but have had limited durability and significant morbidity associated with their use. For this reason, Canadian Cardiovascular Society 2003 guidelines recommended permanent cessation of driving in these patients (for both private and commercial vehicle operation). However, recent advances with newer, continuous-flow devices have resulted in much lower rates of device-related complications and greater use of these devices for destination therapy. The majority of patients now are discharged home and lead active lives subsequently. Based on new evidence applied to the Society's "Risk of Harm" formula, it has been determined that patients with continuous-flow devices who are doing well 2 months post implantation are fit to hold noncommercial class drivers' licenses. Copyright ÂEntities:
Mesh:
Year: 2012 PMID: 22342270 DOI: 10.1016/j.cjca.2011.11.017
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223